Action
Inhibits cell-wall synthesis during bacterial multiplication, leading to cell death. Shows enhanced activity toward gram-negative bacteria compared to natural and penicillinase-resistant penicillins.
Availability
Capsules: 250 mg, 500 mg
Powder for oral suspension: 50 mg/ml and 125 mg/5 ml (pediatric), 200 mg/5 ml, 250 mg/5 ml, 400 mg/5 ml
Tablets: 500 mg, 875 mg
Tablets for oral suspension: 200 mg, 400 mg
Tablets (chewable): 125 mg, 200 mg, 250 mg, 400 mg
Indications and dosages
➣ Uncomplicated gonorrhea
Adults and children weighing at least 40 kg (88 lb): 3 g P.O. as a single dose
Children ages 2 and older weighing less than 40 kg (88 lb): 50 mg/kg P.O. given with probenecid 25 mg/kg P.O. as a single dose
➣ Bacterial endocarditis prophylaxis for dental, GI, and GU procedures
Adults: 2 g P.O. 1 hour before procedure
Children: 50 mg/kg P.O. 1 hour before procedure
➣ Lower respiratory tract infections caused by streptococci, pneumococci, non-penicillinase-producing staphylococci, and Haemophilus influenzae
Adults and children weighing more than 20 kg (44 lb): 875 mg P.O. q 12 hours or 500 mg P.O. q 8 hours
Children weighing less than 20 kg (44 lb): 45 mg/kg/day P.O. in divided doses q 12 hours or 40 mg/kg/day P.O. in divided doses q 8 hours
➣ Ear, nose, and throat infections caused by streptococci, pneumococci, non-penicillinase-producing staphylococci, and H. influenzae; GU infections caused by Escherichia coli, Proteus mirabilis, and Streptococcus faecalis
Adults and children weighing more than 20 kg (44 lb): 500 mg P.O. q 12 hours or 250 mg P.O. q 8 hours
Children weighing less than 20 kg (44 lb): 45 mg/kg/day P.O. in divided doses q 12 hours or 20 to 40 mg/kg P.O. in divided doses q 8 hours
➣ Eradication of Helicobacter pylori to reduce risk of duodenal ulcer recurrence
Adults: 1 g P.O. q 12 hours for 14 days in combination with clarithromycin and lansoprazole, or in combination with lansoprazole alone as 1 g t.i.d. for 14 days
➣ Postexposure anthrax prophylaxis
Adults: 500 mg P.O. t.i.d. for 60 days
Children: 80 mg/kg/day P.O. t.i.d. for 60 days
➣ Skin and skin-structure infections caused by streptococci (alpha- and beta-hemolytic strains), staphylococci, and E. coli
Adults: 500 mg P.O. q 12 hours to 250 mg P.O. q 8 hours. For severe infections, 875 mg P.O. q 12 hours or 500 mg P.O. q 8 hours.
Children older than age 3 months: 25 mg/kg/day P.O. in divided doses q 12 hours or 20 mg/kg/day P.O. in divided doses every 8 hours. For severe infections, 45 mg/kg/day P.O. in divided doses q 12 hours or 40 mg/kg/day P.O. in divided doses every 8 hours.
Dosage adjustment
• Renal impairment
• Hemodialysis
• Infants ages 3 months and younger
Off-label uses
• Chlamydia trachomatis infection in pregnant patients
Contraindications
• Hypersensitivity to drug or any penicillin
Precautions
Use cautiously in:
• severe renal insufficiency, infectious mononucleosis, hepatic dysfunction
• pregnant patients.
Administration
See Ask about history of penicillin allergy before giving.
• Give with or without food.
• Store liquid form in refrigerator when possible.
• Know that maximum dosage for infants ages 3 months and younger is 30 mg/kg/day divided q 12 hours.
Adverse reactions
CNS: lethargy, hallucinations, anxiety, confusion, agitation, depression, dizziness, fatigue, hyperactivity, insomnia, behavioral changes, seizures (with high doses)
GI: nausea, vomiting, diarrhea, bloody diarrhea, abdominal pain, gastritis, stomatitis, glossitis, black "hairy" tongue, furry tongue, enterocolitis, pseudomembranous colitis
GU: vaginitis, nephropathy, interstitial nephritis
Hematologic: eosinophilia, anemia, thrombocytopenia, thrombocytopenic purpura, leukopenia, hemolytic anemia, agranulocytosis, bone marrow depression
Hepatic: cholestatic jaundice, hepatic cholestasis, cholestatic hepatitis, nonspecific hepatitis
Respiratory: wheezing
Skin: rash
Other: superinfections (oral and rectal candidiasis), fever, anaphylaxis
Interactions
Drug-drug. Allopurinol: increased risk of rash
Chloramphenicol, macrolides, sulfonamides, tetracycline: decreased amoxicillin efficacy
Hormonal contraceptives: decreased contraceptive efficacy
Probenecid: decreased renal excretion
Drug-diagnostic tests. Alanine aminotransferase, alkaline phosphatase, eosinophils, lactate dehydrogenase: increased levels
Granulocytes, hemoglobin, platelets, white blood cells: decreased values Direct Coombs' test, urine glucose, urine protein: false-positive results
Drug-food. Any food: delayed or reduced drug absorption
Drug-herbs. Khat: decreased antimicrobial efficacy
Patient monitoring
• Monitor for signs and symptoms of hypersensitivity reaction.
See Evaluate for seizures when giving high doses.
• Monitor patient's temperature and watch for other signs and symptoms of superinfection (especially oral or rectal candidiasis).
Patient teaching
See Instruct patient to immediately report signs and symptoms of hypersensitivity reactions, such as rash, fever, or chills.
• Tell patient he may take drug with or without food.
• Tell patient not to chew or swallow tablets for suspension, because they're not meant to be dissolved in mouth.
• Advise patient to minimize GI upset by eating small, frequent servings of food and drinking plenty of fluids.
• Tell patient taking hormonal contraceptives that drug may reduce contraceptive efficacy. Suggest she use alternative birth control method.
• Inform patient that drug lowers resistance to other types of infections. Instruct him to report new signs and symptoms of infection, especially in mouth or rectum.
• Tell parents they may give liquid form of drug directly to child or may mix it with foods or beverages.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, foods, and herbs mentioned above.